FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CHEN STEPHEN T
2. Issuer Name and Ticker or Trading Symbol

AMARILLO BIOSCIENCES INC [ AMAR ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President,Chairman,CEO,CFO
(Last)          (First)          (Middle)

4134 BUSINESS PARK DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

9/17/2020
(Street)

AMARILLO, TX 79110
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 9/17/2020  P  100 A$0.22 780400 I SPOUSE (1)
Common Stock 9/21/2020  P  800 A$0.16 781200 I SPOUSE (1)
Common Stock 9/22/2020  P  200 A$0.2 781400 I SPOUSE (1)
Common Stock         5749019 D  
Common Stock         12413 D  
Common Stock         39473 I ACTS BIOSCIENCES, INC. (2)
Common Stock         638801 I STC INTERNATIONAL, INC. (3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) SPOUSE - VIRGINIA M CHEN IRA
(2) ACTS BIOSCIENCES, INC. - STEPHEN CHEN IS CHAIRMAN AND MAJOR STOCKHOLDER
(3) STC INTERNATIONAL, INC. - STEPHEN CHEN IS CHAIRMAN, BOARD MEMBER, AND MAJOR STOCKHOLDER

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
CHEN STEPHEN T
4134 BUSINESS PARK DRIVE
AMARILLO, TX 79110
XXPresident,Chairman,CEO,CFO

Signatures
BERNARD COHEN FOR STEPHEN T CHEN9/22/2020
**Signature of Reporting PersonDate